MOTCO’s Takeda Pharmaceutical TAK Stock Holding History

MOTCO’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.27K	Buy	516 +115	+29%	+$1.9K	﹤0.01%	448
2026 Q1	$7.43K	Hold	401	–	–	﹤0.01%	475
2025 Q4	$6.25K	Hold	401	–	–	﹤0.01%	508
2025 Q3	$5.87K	Hold	401	–	–	﹤0.01%	510
2025 Q2	$5.5K	Hold	401	–	–	﹤0.01%	465
2025 Q1	$5.96K	Hold	401	–	–	﹤0.01%	445
2024 Q4	$5.31K	Hold	401	–	–	﹤0.01%	419
2024 Q3	$5.7K	Hold	401	–	–	﹤0.01%	514
2024 Q2	$5.19K	Hold	401	–	–	﹤0.01%	600
2024 Q1	$5.57K	Hold	401	–	–	﹤0.01%	550
2023 Q4	$5.72K	Hold	401	–	–	﹤0.01%	514
2023 Q3	$6.2K	Sell	401 -160	-29%	-$2.48K	﹤0.01%	542
2023 Q2	$8.81K	Buy	561 +160	+40%	+$2.62K	﹤0.01%	512
2023 Q1	$6.61K	Hold	401	–	–	﹤0.01%	488
2022 Q4	$6.26K	Sell	401 -297	-43%	-$4.15K	﹤0.01%	506
2022 Q3	$9K	Buy	698 +297	+74%	+$4.13K	﹤0.01%	518
2022 Q2	$6K	Hold	401	–	–	﹤0.01%	507
2022 Q1	$6K	Hold	401	–	–	﹤0.01%	526
2021 Q4	$5K	Hold	401	–	–	﹤0.01%	526
2021 Q3	$7K	Sell	401 -163	-29%	-$2.74K	﹤0.01%	533
2021 Q2	$9K	Hold	564	–	–	﹤0.01%	507
2021 Q1	$10K	Sell	564 -80	-12%	-$1.44K	﹤0.01%	474
2020 Q4	$12K	Buy	644 +243	+61%	+$4.26K	﹤0.01%	511
2020 Q3	$7K	Hold	401	–	–	﹤0.01%	492
2020 Q2	$7K	Hold	401	–	–	﹤0.01%	455
2020 Q1	$6K	Hold	401	–	–	﹤0.01%	481
2019 Q4	$8K	Hold	401	–	–	﹤0.01%	450
2019 Q3	$7K	Sell	401 -1,726	-81%	-$29.9K	﹤0.01%	445
2019 Q2	$38K	Buy	2,127 +1,726	+430%	+$31.4K	﹤0.01%	404
2019 Q1	$8K	Buy	+401	New	+$8.07K	﹤0.01%	457

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

MOTCO's TAK Position: Q2 2026 in Review

MOTCO increased its Takeda Pharmaceutical (TAK) stake by 29% in Q2 2026, buying an estimated $1.9K and bringing the position to 516 shares worth $8.27K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

MOTCO first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $38K in Q2 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

MOTCO held 516 shares of Takeda Pharmaceutical worth $8.27K as of Q2 2026.
MOTCO bought 115 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.9K.
Takeda Pharmaceutical made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #448 holding.
MOTCO first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
MOTCO's Takeda Pharmaceutical position peaked at $38K in Q2 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.